We are live on ! Find out more
State of Wisconsin Investment Board

State of Wisconsin Investment Board Portfolio holdings

AUM $43.7B
1-Year Est. Return 27.76%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+27.76%
3 Year Est. Return
+95.56%
5 Year Est. Return
+123.77%
10 Year Est. Return
+486.44%
AUM
$35.9B
AUM Growth
+$692M
Cap. Flow
-$639M
Cap. Flow %
-1.78%
Top 10 Hldgs %
16.09%
Holding
1,660
New
123
Increased
659
Reduced
730
Closed
128

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$182M
2
HCA icon
HCA Healthcare
HCA
+$108M
3
PH icon
Parker-Hannifin
PH
+$101M
4
WTW icon
Willis Towers Watson
WTW
+$97.6M
5
GWW icon
W.W. Grainger
GWW
+$95M

Top Sells

Rank Stock Value
1
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$167M
2
AAPL icon
Apple
AAPL
+$88M
3
MSFT icon
Microsoft
MSFT
+$82M
4
JNJ icon
Johnson & Johnson
JNJ
+$78.6M
5
JPM icon
JPMorgan Chase
JPM
+$67M

Sector Composition

Rank Sector Weight
1 Technology 17.85%
2 Financials 16.67%
3 Healthcare 13.41%
4 Consumer Discretionary 10.38%
5 Industrials 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNKD icon
1476
MannKind Corp
MNKD
$1.24B
$223K ﹤0.01%
194,300
+4,300
+2% +$5.95K
TWST icon
1477
Twist Bioscience
TWST
$7.85B
$223K ﹤0.01%
+7,700
New +$204K
BYND icon
1478
Beyond Meat
BYND
$214M
$221K ﹤0.01%
+1,378
New +$154K
CASI
1479
DELISTED
CASI Pharmaceuticals
CASI
$221K ﹤0.01%
6,900
+150
+2% +$4.79K
CUE icon
1480
Cue Biopharma
CUE
$128M
$221K ﹤0.01%
820
+17
+2% +$4.23K
CYCN icon
1481
Cyclerion Therapeutics
CYCN
$18.4M
$215K ﹤0.01%
+939
New +$266K
FTSV
1482
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$215K ﹤0.01%
20,300
+9,500
+88% +$139K
BGC icon
1483
BGC Group
BGC
$5.12B
$214K ﹤0.01%
40,850
-10,141
-20% -$52.6K
MRNS
1484
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$209K ﹤0.01%
12,575
+275
+2% +$4.78K
ABEO icon
1485
Abeona Therapeutics
ABEO
$425M
$206K ﹤0.01%
1,720
+36
+2% +$6.04K
OCUL icon
1486
Ocular Therapeutix
OCUL
$2.25B
$201K ﹤0.01%
45,600
+1,000
+2% +$3.7K
PR
1487
Permian Resources
PR
$18B
$199K ﹤0.01%
26,157
-7,962
-23% -$70.8K
SYBX
1488
DELISTED
Synlogic
SYBX
$195K ﹤0.01%
1,427
+34
+2% +$4.14K
ADMS
1489
DELISTED
Adamas Pharmaceuticals
ADMS
$187K ﹤0.01%
30,200
+700
+2% +$4.03K
OPTN
1490
DELISTED
OptiNose
OPTN
$185K ﹤0.01%
1,740
+40
+2% +$5.27K
EOLS icon
1491
Evolus
EOLS
$536M
$183K ﹤0.01%
12,500
+300
+2% +$5.95K
BRSL
1492
Brightstar Lottery PLC
BRSL
$2.08B
$183K ﹤0.01%
14,088
-4,286
-23% -$58.3K
ALDX icon
1493
Aldeyra Therapeutics
ALDX
$91.7M
$182K ﹤0.01%
30,400
+700
+2% +$5.27K
SNDX icon
1494
Syndax Pharmaceuticals
SNDX
$1.77B
$179K ﹤0.01%
19,200
+400
+2% +$2.92K
TVTY
1495
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$176K ﹤0.01%
10,705
– –
EVLO
1496
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$173K ﹤0.01%
965
+20
+2% +$3.23K
PRTK
1497
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$172K ﹤0.01%
43,100
+900
+2% +$4.28K
CALA
1498
DELISTED
Calithera Biosciences, Inc
CALA
$165K ﹤0.01%
2,120
+45
+2% +$5.11K
FBRX icon
1499
Forte Biosciences
FBRX
$1.57B
$164K ﹤0.01%
66
+2
+3% +$5.93K
KOD icon
1500
Kodiak Sciences
KOD
$2.72B
$161K ﹤0.01%
+13,800
New +$123K
58 59
60
61 62

Similar funds

WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

State of Wisconsin Investment Board's Q2 2019 Portfolio in Review

As of Q2 2019, State of Wisconsin Investment Board held 1,660 positions worth $35.9B, up 2% from $35.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

State of Wisconsin Investment Board's Q2 2019 filing shows 123 new, 659 increased, 730 reduced and 128 closed positions. Its largest new stake was Dow Inc: 892,373 shares worth $44M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $167M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • State of Wisconsin Investment Board's largest Q2 2019 buy was Dow Inc: 892,373 shares worth $44M.
  • State of Wisconsin Investment Board added most to iShares Russell 2000 ETF in Q2 2019, an estimated $182M increase.
  • State of Wisconsin Investment Board's biggest Q2 2019 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $167M.
  • State of Wisconsin Investment Board fully exited DocuSign in Q2 2019, selling an estimated $56.3M.
  • State of Wisconsin Investment Board's ten largest holdings make up 16% of its $35.9B portfolio in Q2 2019.
  • State of Wisconsin Investment Board opened 123 new positions and closed 128 in Q2 2019.
  • State of Wisconsin Investment Board's portfolio value rose 2% quarter-over-quarter to $35.9B.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2019, filed 14 Aug 2019.